# A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

> clinical trial · VERIFIED · 2026-07-24

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Locally Advanced Alveolar Soft Part Sarcoma

- Company: National Cancer Institute (NCI)
- Sector: Locally Advanced Alveolar Soft Part Sarcoma
- Primary source: https://clinicaltrials.gov/study/NCT06066138

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.